The GLP-1 boom is creating opportunities far beyond today’s weight-loss medications. Companies are exploring new combinations and formulations—and seeking patents to protect those ideas.
For businesses entering this market, understanding those patents could be just as important as spotting the next opportunity.
New Treatments, New Patent Questions
On September 23, Artelo Biosciences announced a provisional patent application for an experimental treatment used alone or alongside GLP-1 drugs such as semaglutide, the active ingredient in Ozempic and Wegovy. The obesity research is still at the animal-study stage, and the filing is not a granted patent. But it offers a timely example of companies pursuing new inventions around existing treatments. Read the announcement.
At the same time, older patents are beginning to expire in certain markets.
Semaglutide’s compound patent expired in India in March 2026. Yet Novo Nordisk subsequently reported lawsuits alleging that competing oral versions infringed separate patents covering how the medicine was formulated. Novo Nordisk’s report.
An Expired Patent Doesn’t Mean a Clear Path
That illustrates a business lesson: one patent expiring doesn’t necessarily mean the path to market is clear.
A new formulation or combination may involve other patent rights. Even securing a patent for an improvement does not automatically give a company permission to use the underlying technology. That is why freedom to operate, or FTO, matters: it examines whether a planned product could infringe someone else’s patent rights. WIPO’s explanation.
For innovators and investors, this creates a need for better visibility before committing significant time and money.
Which companies hold relevant patents? Where are competitors developing new technology? What deserves closer review before a partnership, investment, or product launch?
Where Ontologics Comes In
Ontologics helps bring that picture into focus.
Through patent portfolio analysis and competitive intelligence, Ontologics helps businesses understand the technologies, companies, and patent positions shaping their opportunities. Those insights give business leaders and legal teams a stronger starting point for deeper investigation.
In a market moving as quickly as GLP-1 health, understanding the patent landscape belongs near the beginning of the business decision.
Get a free Executive IP Analytics Report from Ontologics to explore a company’s patent strengths, competitive position, and emerging opportunities.
Get a Free IP Analytics Report and See Your Patent Strength in Just 24 Hours!
Get a fast, evidence-based snapshot of your patent strength before you make your next investment or strategic move. Our proprietary AI analyzes your IP in minutes and delivers insights you won’t find anywhere else.